OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Journals

Relevant Topics

Lymphatic Filariasis

Share this page

Lymphatic filariasis, commonly known as elephantiasis, is a painful and profoundly disfiguring disease. While the infection is usually acquired in childhood, its visible manifestations occur later in life, causing temporary or permanent disability. In endemic countries, lymphatic filariasis has a major social and economic impact.The disease is caused by three species of thread-like nematode worms, known as filariae – Wuchereria bancrofti, Brugia malayi and Brugia timori
Most infected people are asymptomatic and will never develop clinical symptoms, despite the fact that the parasite damages the lymph system. A small percentage of persons will develop lymphedema. This is caused by improper functioning of the lymph system that results in fluid collection and swelling. This mostly affects the legs, but can also occur in the arms, breasts, and genitalia. Most people develop these clinical manifestations years after being infectedeople infected with adult worms can take a yearly dose of medicine, called diethylcarbamazine (DEC), that kills the microscopic worms circulating in the blood. While this drug does not kill all of the adult worms, it does prevent infected people from giving the disease to someone else.
• Carefully wash the swollen area with soap and water every day. • Elevate and exercise the swollen arm or leg to move the fluid and improve the lymph flow. • Disinfect any wounds. Use antibacterial or antifungal cream if necessary.
Globally, 1103 million people live in the countries where preventive treatment for lymphatic filariasis is required. WHO's African and South-East Asia regions harbour 94% of the population living in endemic areas, and 98% of the infected population. Of the total population requiring preventive chemotherapy for lymphatic filariasis, 632 million (57%) live in the South-East Asia Region (9 endemic countries) and 410 million (37%) live in the African Region (35 countries). The Region of the Americas, Eastern Mediterranean Region and Western Pacific Region (with 4, 3 and 22 endemic countries, respectively) together account for 6% of global distribution.
Most infected people are asymptomatic and will never develop clinical symptoms, despite the fact that the parasite damages the lymph system. A small percentage of persons will develop lymphedema. This is caused by improper functioning of the lymph system that results in fluid collection and swelling. This mostly affects the legs, but can also occur in the arms, breasts, and genitalia. Most people develop these clinical manifestations years after being infectedeople infected with adult worms can take a yearly dose of medicine, called diethylcarbamazine (DEC), that kills the microscopic worms circulating in the blood. While this drug does not kill all of the adult worms, it does prevent infected people from giving the disease to someone else.
• Carefully wash the swollen area with soap and water every day. • Elevate and exercise the swollen arm or leg to move the fluid and improve the lymph flow. • Disinfect any wounds. Use antibacterial or antifungal cream if necessary.
Globally, 1103 million people live in the countries where preventive treatment for lymphatic filariasis is required. WHO's African and South-East Asia regions harbour 94% of the population living in endemic areas, and 98% of the infected population. Of the total population requiring preventive chemotherapy for lymphatic filariasis, 632 million (57%) live in the South-East Asia Region (9 endemic countries) and 410 million (37%) live in the African Region (35 countries). The Region of the Americas, Eastern Mediterranean Region and Western Pacific Region (with 4, 3 and 22 endemic countries, respectively) together account for 6% of global distribution.

Expert PPTs

Srinivasan Shanmugam
Lipid Based Oral Drug Delivery System (LBODDS)
PPT Version | PDF Version
Ti Zhang
Lymphatic drug delivery
PPT Version | PDF Version

International Conferences 2018-19

Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Conferences By Continents

USA & Americas

Asia-Pacific & Middle East

Europe

Conferences by Subject

Contact Us

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

Content of this site is vailable under Creative Commons Attribution 4.0 License
Copyright © 2018 OMICS International All Rights Reserved.